Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News April 23rd 2010

April 23rd 2010

Integrating community pharmacy into the care of people with Diabetes
This toolkit has been produced to aid pharmacy services and local representative committees. However it may also be of interest to those commissioning pharmaceutical services and services for people with diabetes (NHS Evidence)

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis
In the US population, screening for type 2 diabetes is cost effective when started between the ages of 30 years and 45 years, with screening repeated every 3—5 years (The Lancet)

Pathophysiology of Diabetes in the Elderly
Metabolic alterations in older people with diabetes are distinct from those that occur in the young. Because of these distinct metabolic abnormalities, the therapeutic approach to older patients should be different (Clinical Geriatrics)

Diagnosis, Classification, and Lifestyle Treatment of Diabetes
Medical professionals can expect to spend a large portion of their time caring for diabetic patients in inpatient and outpatient settings as the prevalence of this disease increases steadily (Clinical Diabetes)

Discovery About Wound-Healing Process Could Help Diabetics and Others with Slow-to-Heal Wounds
In the study, the immune system cells that impeded the healing process are called natural killer T cells (Loyola University Health System)

Beta-Cell Mass Dynamics and Islet Cell Plasticity in Human Type 2 Diabetes
Decreased beta-cell volume may be a consequence, rather than a cause, of type 2 diabetes, mediated by increased apoptosis and attenuated beta-cell regeneration, researchers suggest (American Diabetes Association)

Relationship of Insulin Resistance to Macro- and Microvasculature Reactivity in Hypertension
The complication of IR in hypertensive patients without obvious CV disease/risk factors may be related to impaired macrovasculature rather than microvasculature reactivity (American Journal of Hypertension)

Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes
A prolonged interruption of insulin delivery during overnight closed-loop glucose control to prevent hypoglycaemia was not associated with an increased risk of hyperglycaemia in young people with T1D (Diabetic Medicine)

Non-Invasive Easy Check Breath Glucose Technology
PositiveID Corporation to Conduct Comparative Laboratory Analysis of Its Non-Invasive Easy Check Breath Glucose Technology versus Current “Finger Stick” Blood Glucose Testing Method (Miami Herald)

Primary Care Diabetes
(April 2010)

Categories: News Pre-2012

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

AstraZenecaNovo NordiskBoehringer IngelheimNapp Diabetes

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes CareAbout Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership